Defining rare conditions in the era of personalized medicine

被引：1
|
作者：
O'Connor, Daniel J. [1 ,2 ]
Gabaldo, Michela [1 ,3 ]
Aartsma-Rus, Annemieke [1 ,4 ,5 ]
Jonker, Anneliene Hechtelt [1 ,6 ]
机构：
[1] Therapies Sci Comm, Int Rare Dis Res Consortium, Paris, France
[2] Assoc British Pharmaceut Ind, London, England
[3] Aptuit Evotec Co, Verona, Italy
[4] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands
[5] Dutch Ctr RNA Therapeut, Leiden, Netherlands
[6] Univ Twente, Enschede, Netherlands
来源：
NATURE REVIEWS DRUG DISCOVERY | 2023年 / 22卷 / 11期
关键词：
D O I：
10.1038/d41573-023-00145-2
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
The total number of rare conditions is debated, partly because of the variety of definitions of what constitutes rare. A broader consensus view of what rare means, based on improved understanding of individual group and patient clinicopathological characteristics, will help maximize the impact of technological advances in therapeutic development programmes.
引用
收藏
页码：857 / 858
页数：2
相关论文
共 50 条
  • [41] Metabolomics of infectious diseases in the era of personalized medicine
    Rahman, Mahbuba
    Schellhorn, Herb E.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [42] Locoregional radiation therapy in the era of personalized medicine
    Crisp, Alisa
    Truong, Pauline
    BREAST CANCER MANAGEMENT, 2012, 1 (03) : 191 - 194
  • [43] Chemistry of Fluorinated Pyrimidines in the Era of Personalized Medicine
    Gmeiner, William H.
    MOLECULES, 2020, 25 (15):
  • [44] Treatment of acromegaly in the era of personalized and predictive medicine
    Puig Domingo, Manuel
    CLINICAL ENDOCRINOLOGY, 2015, 83 (01) : 3 - 14
  • [45] The Linear Quadratic Model in the Era of Personalized Medicine
    Peacock, J.
    Li, C.
    Grass, D.
    Frakes, J. M.
    Subramanian, A.
    Scott, J. G.
    Liu, X.
    Torres-Roca, J. F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E546 - E547
  • [46] Reassessing Cancer Survivorship in the Era of Personalized Medicine
    Dizon, Don S.
    ONCOLOGY-NEW YORK, 2019, 33 (12): : 491 - 493
  • [47] Personalized cancer medicine: era of promise and progress
    Hutchinson, Lisa
    NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (03) : 121 - 121
  • [48] Breast cancer pharmacogenetics in the era of personalized medicine
    Yao S.
    Maghsoudlou D.
    Ambrosone C.B.
    Current Breast Cancer Reports, 2012, 4 (4) : 271 - 281
  • [49] Fear of Cancer Recurrence in an Era of Personalized Medicine
    Thewes, Belinda
    Husson, Olga
    Poort, Hanneke
    Custers, Jose A. E.
    Butow, Phyllis N.
    McLachlan, Sue-Anne
    Prins, Judith B.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (29) : 3275 - +
  • [50] Chemotherapy for Lung Cancer in the Era of Personalized Medicine
    Lee, Seung Hyeun
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2019, 82 (03) : 179 - 189
12345